Sonova Holding AG, CH0012549785

Sonova launches AI products. Goldman upgrades Sonova stock to Buy

Published on 10/18/2026 at 13:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sonova extends AI beyond hearing aids on October 14, 2026. Sonova stock has a CHF315.00 Goldman target after CHF230.00 before November results.

AI expansion and earnings dates

  • Sonova introduced Roger On Sphere and Integro on October 14, 2026.
  • Goldman Sachs set a CHF 315.00 target after CHF 230.00 on October 8, 2026.
  • Fiscal year 2025/26 sales reached CHF 3,605.9 million, up 5.9 percent in local currencies.
  • Sonova is scheduled to report first-half fiscal 2027 results on November 12, 2026.
Sonova CH0012549785: Fotorealistische Audiologie-Untersuchung mit Patient, Kopfhörern und Audiogramm-Bildschirm in moderner Klinik, Illustration mit AI erstellt.

Sonova Holding AG (ISIN CH0012549785) introduced new artificial-intelligence products on October 14, 2026, extending its technology beyond hearing aids. According to Financial Times, the Roger On Sphere remote microphone and Advanced Bionics Integro sound processors broaden Sonova's AI offering across hearing aids, wireless communication and cochlear implants.

AI moves beyond hearing aids

Roger On Sphere uses real-time AI to separate speech from background noise and is designed to connect directly with compatible hearing devices without external receiver hardware. The product is scheduled to become available from mid-November 2026, while Integro has received TÜV approval and is being introduced in selected European markets, according to the same October 14 company announcement.

What does the target imply?

Goldman Sachs upgraded Sonova from Neutral to Buy on October 8, 2026, and raised its price target from CHF 230.00 to CHF 315.00. Investing.com reported that the bank expects constant-currency revenue growth of 7.8 percent in fiscal 2027, compared with 6.6 percent consensus, and adjusted EBIT growth of 12.6 percent versus 6.5 percent consensus. The target change gives investors a quantified measure of how sharply the bank's view improved.

Three milestones frame the story

Sonova reported fiscal year 2025/26 sales of CHF 3,605.9 million, up 5.9 percent in local currencies, in its May 18, 2026 results release, according to the company's official newsroom. Goldman Sachs followed with its October 8 target change, and Sonova then presented the October 14 product expansion. The sequence links a proven growth base with a fresh technology push.

Next dates for shareholders

Investing.com identified November 12, 2026 as the date for Sonova's first-half fiscal 2027 results. Roger On Sphere is expected from mid-November 2026, creating two closely timed milestones for assessing product uptake and the company's growth outlook.

Stock context and investor takeaway

Sonova's reported sales growth, the CHF 315.00 target and the planned November results date give the stock a defined set of company-specific reference points. The key question is whether the AI portfolio can translate technical differentiation into broader adoption and sustained revenue growth.

Sonova stock key facts

  • Company: Sonova Holding AG
  • ISIN: CH0012549785
  • Ticker: SOON
  • Primary exchange: SIX Swiss Exchange
  • Sector / Industry: Healthcare / Medical Devices
  • CEO: Eric Alain Bernard

Market context: Market report SMI.

The latest company developments are collected in More news and analyses on Sonova stock.

Disclaimer...
en | CH0012549785 | SONOVA HOLDING AG | boerse | 70353592 | bgmi